Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Ethnic differences in pharmacogenetically relevant genes.

Engen RM, Marsh S, Van Booven DJ, McLeod HL.

Curr Drug Targets. 2006 Dec;7(12):1641-8. Review.

PMID:
17168839
2.

Pharmacogenomics: the influence of genomic variation on drug response.

Thomas FJ, McLeod HL, Watters JW.

Curr Top Med Chem. 2004;4(13):1399-409. Review.

PMID:
15379653
3.

Cancer pharmacogenomics: SNPs, chips, and the individual patient.

McLeod HL, Yu J.

Cancer Invest. 2003;21(4):630-40. Review.

PMID:
14533451
4.

Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals.

McLeod HL, Pritchard SC, Githang'a J, Indalo A, Ameyaw MM, Powrie RH, Booth L, Collie-Duguid ES.

Pharmacogenetics. 1999 Dec;9(6):773-6.

PMID:
10634140
5.

The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia.

Tumer TB, Ulusoy G, Adali O, Sahin G, Gozdasoglu S, Arinç E.

Am J Hematol. 2007 Oct;82(10):906-10.

6.
7.

Determination of intra-ethnic differences in the polymorphisms of thiopurine S-methyltransferase in Chinese.

Zhang JP, Zhou SF, Chen X, Huang M.

Clin Chim Acta. 2006 Mar;365(1-2):337-41.

PMID:
16223474
8.

Prospects and limits of pharmacogenetics: the thiopurine methyl transferase (TPMT) experience.

van Aken J, Schmedders M, Feuerstein G, Kollek R.

Am J Pharmacogenomics. 2003;3(3):149-55. Review.

PMID:
12814323
9.

Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.

Cao Q, Zhu Q, Shang Y, Gao M, Si J.

Digestion. 2009;79(1):58-63. doi: 10.1159/000205268.

PMID:
19252404
10.

Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy.

Evans WE.

Ther Drug Monit. 2004 Apr;26(2):186-91. Review.

PMID:
15228163
11.

Pharmacogenomics: catechol O-methyltransferase to thiopurine S-methyltransferase.

Weinshilboum RM.

Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):539-61. Review.

PMID:
16807786
12.

Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.

Wang L, Weinshilboum R.

Oncogene. 2006 Mar 13;25(11):1629-38. Review.

PMID:
16550163
13.

[Cancer pharmacogenetics: study of genetically determined variations on cancer susceptibility due to xenobiotic exposure].

Quiñones L, Lee K, Varela F N, Escala M, García K, Godoy L, Castro A, Soto J, Saavedra I, Cáceres D.

Rev Med Chil. 2006 Apr;134(4):499-515. Review. Spanish.

14.

Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2 - *24).

Ujiie S, Sasaki T, Mizugaki M, Ishikawa M, Hiratsuka M.

Pharmacogenet Genomics. 2008 Oct;18(10):887-93. doi: 10.1097/FPC.0b013e3283097328.

PMID:
18708949
15.

Race, ethnicity, ancestry, and pharmacogenetics.

Urban TJ.

Mt Sinai J Med. 2010 Mar-Apr;77(2):133-9. doi: 10.1002/msj.20168. Review.

PMID:
20309922
16.

Genetic analyses of thiopurine methyltransferase polymorphisms in Greenlandic and Danish populations.

Toft N, Nygaard U, Gregers J, Schmiegelow K.

Acta Paediatr. 2006 Dec;95(12):1665-7.

PMID:
17129980
17.

Pharmacogenomics in the Americas: the impact of genetic admixture.

Suarez-Kurtz G, Pena SD.

Curr Drug Targets. 2006 Dec;7(12):1649-58. Review.

PMID:
17168840
18.

Overview of pharmacogenetics in anticoagulation therapy.

Hill CE, Duncan A.

Clin Lab Med. 2008 Dec;28(4):513-24. doi: 10.1016/j.cll.2008.09.002. Review.

PMID:
19059059
19.

Highly multiplexed genotyping of thiopurine s-methyltransferase variants using MALD-TOF mass spectrometry: reliable genotyping in different ethnic groups.

Schaeffeler E, Zanger UM, Eichelbaum M, Asante-Poku S, Shin JG, Schwab M.

Clin Chem. 2008 Oct;54(10):1637-47. doi: 10.1373/clinchem.2008.103457.

20.

Pharmacogenetics: has it reached the clinic?

Schwartz JB.

J Gend Specif Med. 2002 Mar-Apr;5(2):13-8.

PMID:
11974670

Supplemental Content

Support Center